Quote:
Originally Posted by heero_yuy
GSK in the UK is working with its French rival on the vaccine so it's likely that it'll be manufactured in the UK as well so no need for the EU involvement.
Source |
GSK doesn't really have vaccine manufacturing in the UK. The bulk of the local vaccine manufacturing is in Rixensart in Belgium. Blimmin huge site that too. However, it's not clear if the vaccine final formulation will be Sanofi, GSK or both.
(super geeky background, GSK is very good at whole viral vaccines, especially egg based products. Sanofi good at viral component vaccines)
On the regulation, the UK regulator (MHRA) is being super flexible on regulations so we would very likely take EMA approval directly even if approved after the end of the transition period. Where there's a will, there's a way...